## Diagnosis and Classification **Key Point:** This patient meets diagnostic criteria for gestational diabetes mellitus (GDM) using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria, which recommend a single 75-g OGTT at 24–28 weeks. One abnormal value is sufficient for diagnosis. ### IADPSG Diagnostic Thresholds (75-g OGTT) | Time Point | Threshold (mg/dL) | | --- | --- | | Fasting | ≥92 | | 1-hour | ≥180 | | 2-hour | ≥153 | This patient has **two abnormal values** (1-hour 185 mg/dL and 2-hour 155 mg/dL), confirming GDM diagnosis. ## Management Algorithm ```mermaid flowchart TD A[GDM Diagnosed at 24-28 weeks]:::outcome --> B[Initiate MNT + SMBG]:::action B --> C{Glycemic targets met?}:::decision C -->|Yes| D[Continue MNT + monitoring]:::action C -->|No after 2 weeks| E[Add pharmacotherapy]:::action E --> F[Insulin or metformin]:::action A --> G[Fasting glucose < 95 mg/dL]:::outcome A --> H[Postprandial glucose < 140 mg/dL]:::outcome ``` ## First-Line Intervention **High-Yield:** Medical nutrition therapy (MNT) is the first-line treatment for all newly diagnosed GDM. Self-monitoring of blood glucose (SMBG) 4 times daily (fasting + 2 hours after each meal) allows assessment of glycemic control. **Clinical Pearl:** Approximately 80–85% of GDM cases are managed with MNT alone; only 15–20% require pharmacotherapy. Reassessment in 2 weeks determines if medication is needed. ### Why MNT is Effective - Reduces postprandial glucose spikes - Improves insulin sensitivity - Avoids unnecessary medication exposure in pregnancy - Reduces maternal and fetal complications when targets are met ## Glycemic Targets in GDM - **Fasting:** < 95 mg/dL - **1-hour postprandial:** < 140 mg/dL - **2-hour postprandial:** < 120 mg/dL **Key Point:** If targets are not achieved after 2 weeks of MNT, insulin is the preferred agent (metformin and glyburide are alternatives but insulin is safest in pregnancy).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.